NNMT expression increases significantly with obesity and aging, particularly in white adipose tissue and skeletal muscle
Joo NS, Irokawa T, Wu JV, Robbins RC, Whyte RI, Wine JJ
Description BPC-157+TB-500 20mg | Research Use Only This peptide blend is listed for laboratory research involving peptide signaling, cell-response models, and analytical study design
Contraindications and precautions Consider avoiding DSIP or consulting a physician if: Pregnant or breastfeeding (insufficient safety data) Taking naloxone or other opioid antagonists (may block effects) Using medications metabolized by peptidases (potential interactions) History of immune disorders (theoretical immunogenicity concern) Already using multiple sleep medications Drug interactions Because DSIP degrades via amino-peptidases in blood, medications affecting these enzymes (like the ACE inhibitor captopril) could theoretically alter DSIP metabolism
No peptide discussed in this guide has received FDA approval for treating multiple sclerosis
